866-997-4948(US-Canada Toll Free)

Exact Sciences Corporation (EXAS) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 45 Pages


Exact Sciences Corporation (Exact) is a molecular diagnostics company that focuses on the early detection and prevention of colorectal cancer. The Company\'s proprietary non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology is used to detect presence of colorectal pre-cancer and cancer. Its Cologuard test includes methods detects pre-cancerous polyps, DNA that sheds into stool and four stages of colorectal cancer. It contains DNA markers and protein markers to detect blood in stool utilizing an antibody-based Fecal Immunochemical Test (FIT). Its sDNA-based screening detects both pre-cancers and cancers. EXACT is headquartered in Madinson in Wisconsin, the US.

The company strategically focuses on to obtain FDA clearance for commercialization of Cologuard test. It also intends to maximize its patent portfolio against third parties to cover the methods to detect colorectal and other cancers.

This report is a source for data, analysis and actionable intelligence on the Exact Sciences Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Exact Sciences Corporation - Business Description 5

Key Facts 6
Exact Sciences Corporation - Major Products and Services 7
Exact Sciences Corporation Pipeline Products by Equipment Type 8
Exact Sciences Corporation Pipeline Products by Development Stage 10
Exact Sciences Corporation Pipeline Products by Therapy Area 12
Exact Sciences Corporation Pipeline Products by Trial Phase 14
Exact Sciences Corporation Pipeline Products by Milestone Summary 15
Automation Analytic Platform 17
Automation Analytic Platform Product Status 17
Automation Analytic Platform Product Description 17
Cologuard 18
Cologuard Product Status 18
Cologuard Product Description 18
Cologuard Product Milestone 18
Cologuard Clinical Trial 19
Cologuard Product Patent Details 25
Cologuard - CLIA Lab Test 32
Cologuard - CLIA Lab Test Product Status 32
Cologuard - CLIA Lab Test Product Description 32
Diagnostic Assay - Esophageal Cancer 33
Diagnostic Assay - Esophageal Cancer Product Status 33
Diagnostic Assay - Esophageal Cancer Product Description 33
Diagnostic Assay - Inflammatory Bowel Disease 34
Diagnostic Assay - Inflammatory Bowel Disease Product Status 34
Diagnostic Assay - Inflammatory Bowel Disease Product Description 34
Diagnostic Assay - Pancreatic Cancer 35
Diagnostic Assay - Pancreatic Cancer Product Status 35
Diagnostic Assay - Pancreatic Cancer Product Description 35
Exact Sciences Corporation - Key Competitors 36
Exact Sciences Corporation - Key Employees 37
Exact Sciences Corporation - Key Employee Biographies 38
Exact Sciences Corporation - Locations And Subsidiaries 39
Head Office 39
Recent Developments 40
Exact Sciences Corporation, Recent Developments 40
Oct 30, 2012: Exact Sciences Reports Revenue Of $1m In Q3 2012 40
Oct 18, 2012: Exact Sciences Presents Scientific Poster At American Association for Cancer Research Meeting 40
Jul 25, 2012: Exact Sciences Reports Revenue Of $1m In Q2 2012 40
May 01, 2012: Exact Sciences Reports Revenue Of $1m In Q1 2012 41
Mar 09, 2012: Exact Sciences Reports Revenue Of $4.2m In 2011 41
Feb 20, 2012: Exact Sciences Appoints Laura S Stoltenberg As Chief Commercial Officer 41
Feb 16, 2012: Exact Sciences Promotes Maneesh K Arora To COO 42
Jan 18, 2012: Mayo Clinic: New Test Offers Greater Accuracy In Early Detection Of Colorectal Cancer 42
Nov 03, 2011: Exact Sciences Reports Revenue Of $1m In Q3 2011 43
Aug 02, 2011: Exact Sciences Reports Total Revenues Of $1m For Q2 2011 43

Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Table


Exact Sciences Corporation, Key Facts 1
Exact Sciences Corporation Key Pipeline Products by Equipment Type 1
Exact Sciences Corporation Key Pipeline Products by Therapy Area 1
Exact Sciences Corporation Key Pipeline Products by Development Stage 1
Exact Sciences Corporation Key Pipeline Products by Trial Phase 1
Exact Sciences Corporation, Key Facts 6
Exact Sciences Corporation, Major Products and Services 7
Exact Sciences Corporation Number of Pipeline Products by Equipment Type 8
Exact Sciences Corporation Pipeline Products by Equipment Type 9
Exact Sciences Corporation Number of Pipeline Products by Development Stage 10
Exact Sciences Corporation Pipeline Products by Development Stage 11
Exact Sciences Corporation Number of Pipeline Products by Therapy Area 12
Exact Sciences Corporation Pipeline Products by Therapy Area 13
Exact Sciences Corporation Number of Pipeline Products by Trial Phase 14
Exact Sciences Corporation Pipeline Products by Trial Phase 14
Exact Sciences Corporation Number of Pipeline Products By Milestone Summary 15
Exact Sciences Corporation Pipeline Products by Milestone Summary 16
Automation Analytic Platform - Product Status 17
Automation Analytic Platform - Product Description 17
Cologuard - Product Status 18
Cologuard - Product Description 18
Cologuard - Product Milestone 18
Cologuard - NIH Multi-Center Study Demonstrates Significant Increase In Pre-Malignant Polyp Detection 19
Cologuard - A Study Of Advanced Noninvasive DNA Test For Colorectal Cancer 20
Cologuard - Stool-Based DNA Technology Clinical Study Results 21
Cologuard - A Study On Colorectal Cancer (CRC) Screening Methods Prefer Stool-Based DNA Technology (sDNA) Over Others 22
Cologuard - Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer: DeeP-C Study 23
Cologuard - Patent Details1 25
Cologuard - Patent Details2 26
Cologuard - Patent Details3 26
Cologuard - Patent Details4 27
Cologuard - Patent Details5 27
Cologuard - Patent Details6 28
Cologuard - Patent Details7 28
Cologuard - Patent Details8 29
Cologuard - Patent Details9 29
Cologuard - Patent Details10 30
Cologuard - Patent Details11 30
Cologuard - Patent Details12 31
Cologuard - CLIA Lab Test - Product Status 32
Cologuard - CLIA Lab Test - Product Description 32
Diagnostic Assay - Esophageal Cancer - Product Status 33
Diagnostic Assay - Esophageal Cancer - Product Description 33
Diagnostic Assay - Inflammatory Bowel Disease - Product Status 34
Diagnostic Assay - Inflammatory Bowel Disease - Product Description 34
Diagnostic Assay - Pancreatic Cancer - Product Status 35
Diagnostic Assay - Pancreatic Cancer - Product Description 35
Exact Sciences Corporation, Key Employees 37
Exact Sciences Corporation, Key Employee Biographies 38

List of Chart


Exact Sciences Corporation Key Pipeline Products by Equipment Type 1
Exact Sciences Corporation Pipeline Products by Equipment Type 8
Exact Sciences Corporation Pipeline Products by Development Stage 10
Exact Sciences Corporation Pipeline Products by Therapy Area 12
Exact Sciences Corporation Pipeline Products by Trial Phase 14
Exact Sciences Corporation Pipeline Products by Milestone Summary 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *